Brief: PAION Gets UK MHRA Approval Of Byfavo For Procedural Sedation

PAION AG

29/06/2021 13:05

June 29 (Reuters) - PAION AG  PA8G.DE :
    * PAION RECEIVES UK MHRA APPROVAL OF BYFAVO (REMIMAZOLAM)
FOR
PROCEDURAL SEDATION
    * DECISION FOLLOWS APPROVAL OF EUROPEAN COMMISSION IN EU
(INCLUDING EUROPEAN ECONOMIC AREA (EEA) COUNTRIES) IN MARCH
2021.
    * BASED ON POSITIVE RESULTS IN EUROPEAN PHASE III TRIAL IN
THIS
INDICATION, PAION PLANS TO SUBMIT AN EXTENSION VARIATION TO
MARKETING AUTHORIZATION FOR REMIMAZOLAM FOR GENERAL ANESTHESIA
BY END OF 2021

Source text for Eikon:  ID:nEQ87MF8Da 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))